CITADEL ADVISORS LLC

Position in DWTX — Dogwood Therapeutics, Inc.

CIK 1423053 MIAMI, FL

Back to DWTX Full portfolio

Position in DWTX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$18,904

+$18,904 QoQ

Shares Held

11,742

-64.7% QoQ

Ownership

0.035%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

of 15 holders

Holding Since

Jun 2021

5 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in DWTX Over Time

Shares Held

Position Value (USD)

Derivatives in DWTX

reported options exposure · as of Dec 31, 2022

CallValue

CallShares

37,400

PutValue

PutShares

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,175,465,875 across 436 Biotechnology names. DWTX ranks #419 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ONC	BeOne Medicines Ltd.	1,425,517	$406,229,578
2	BBIO	BridgeBio Pharma, Inc.	3,760,028	$280,046,885
3	INSM	INSMED Inc	2,556,973	$272,624,460
4	MDGL	Madrigal Pharmaceuticals, Inc.	507,233	$272,358,759
5	VRTX	Vertex Pharmaceuticals Inc / Ma	510,430	$253,545,893
6	JAZZ	Jazz Pharmaceuticals plc	1,006,676	$242,578,715
7	MANE	Veradermics, Inc	1,877,775	$230,853,658
8	ROIV	Roivant Sciences Ltd.	5,576,261	$197,343,876

All Filings in DWTX

Export CSV

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$18,904	11,742	—	Shares	Defined	2026-08-14
2023-06-30 VIRI	—	33,298	+665860.0%	Shares	Defined	2023-08-14
2022-12-31 VIRI	—	5	-100.0%	Shares	Defined	2023-02-14
2022-12-31 VIRI	—	37,400	-57.1%	Call	Defined	2023-02-14
2022-09-30 VIRI	—	117,800	—	Put	Defined	2022-11-14
2022-09-30 VIRI	—	87,200	—	Call	Defined	2022-11-14
2021-06-30 VIRI	—	10,100	—	Shares	Defined	2021-08-16
No filing history on record for this holder in this stock.